TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mangoceuticals, Inc. ( (MGRX) ) has provided an announcement.
On May 23, 2025, Mangoceuticals, Inc. entered into Subscription Agreements with two accredited investors, resulting in the issuance of 70,454 shares of common stock and warrants to purchase 35,227 shares, raising $116,249. The Investor Warrants have specific exercise conditions and beneficial ownership limitations. Additionally, on May 27, 2025, the company amended a previous promissory note with Indigo Capital LP, allowing conversion into common stock and removing mandatory prepayment requirements. Furthermore, Mangoceuticals entered a digital marketing agreement with Levo Healthcare Consulting, Inc., issuing 120,000 shares of restricted common stock in exchange for services starting June 1, 2025. These strategic financial moves aim to enhance the company’s capital structure and marketing capabilities.
More about Mangoceuticals, Inc.
Average Trading Volume: 283,338
Technical Sentiment Signal: Sell
Current Market Cap: $26.7M
See more data about MGRX stock on TipRanks’ Stock Analysis page.